Maintenance Notice (4:30 AM - 11:00 AM December 21, 2024): This website is scheduled to be unavailable due to maintenance. We appreciate your patience and understanding.
Published TCIMAIL newest issue No.197
Maximum quantity allowed is 999
Size | Unit Price | Belgium | Japan* | Quantity |
---|---|---|---|---|
10EACH |
60,00 €
|
Contact Us | 17 |
|
*Stock available in Belgium will be delivered in 1 to 3 days
*Stock available in Japan will be delivered in 1 to 2 weeks (excludes regulated items and dry ice shipments).
Contents (per one capsule)
Directions for Use
Related Products
Product Number | R0296 |
Molecular Formula / Molecular Weight | C__1__8H__2__8F__6N__6OP__2 = 520.40 |
Physical State (20 deg.C) | Solid |
Storage Temperature | Refrigerated (0-10°C) |
Condition to Avoid | Heat Sensitive |
CAS RN | 128625-52-5 |
Appearance | White to Almost white capsule |
Functionality test (conversion ratio) | min. 95.0 % |
Pictogram | |
Signal Word | Warning |
Hazard Statements | H302 : Harmful if swallowed. H317 : May cause an allergic skin reaction. H410 : Very toxic to aquatic life with long lasting effects. |
Precautionary Statements | P261 : Avoid breathing dust. P273 : Avoid release to the environment. P264 : Wash skin thoroughly after handling. P280 : Wear protective gloves. P391 : Collect spillage. P333 + P313 : If skin irritation or rash occurs: Get medical advice/ attention. |
UN Number | UN3077 |
Class | 9 |
Packing Group | III |
HS Number | 3822190090 |
Reagents for condensation capsule (1H-benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate) (one capsule) was added to a solution of 4-bromobenzoic acid (40 mg, 0.20 mmol, 1.0 eq.) and morpholine (17 μL, 0.20 mmol, 1.25 eq.) in DMF (1 mL) at room temperature and the mixture was stirred for 2 hours. The reaction solution was diluted with ethyl acetate (5 mL) and filtered through Celite. The organic layer was washed with 1 mol/L HCl aq. (5 mL), sat. NaHCO3 aq. (5 mL) and brine (20 mL), dried over sodium sulfate and concentrated under reduced pressure. The crude product was purified by silica gel chromatography (hexane: ethyl acetate = 1:1 - 1:2) to afford (4-bromophenyl)(morpholino)methanone (65 mg, 97% yield) as a white solid.
The reaction mixture was monitored by UPLC.
The shape of the capsule is like below image and each capsule includes 1H-benzotriazol-1-yloxytripyrrolidinophosphonium hexafluorophosphate (ca. 0.25 mmol).
The material of the capsule is water-soluble HPMC (hydroxypropyl methylcellulose).
(4-Bromophenyl)(morpholino)methanone
1H NMR (400 MHz, CDCl3); δ 7.57 (d, J = 8.4 Hz, 2H), 7.30 (d, J = 8.4 Hz, 2H), 3.74-3.44 (m, 8H).
The requested SDS is not available.
Please Contact Us for more information.
A sample C of A for this product is not available at this time.
The requested analytical chart is not available. Sorry for the inconvenience.